Breakthrough Treatment for Hepatobiliary Cancer
The Inserm Institute for Viral and Liver Diseases, University of Strasbourg France, is looking for a talented and driven scientist to join Prof. Baumert’s highly ambitious FIBCAN program funded by a five-year ERC Advanced Grant of the European Research Council. The program is highly translational aiming to deliver transformative solutions for liver cancer. The successful candidate will contribute to drive and lead the preclinical development of breakthrough therapies for hepatobiliary cancer in collaboration with Pharma. A background in cancer research or immunology and experience in working in an international environment would be desirable. Our program is based on key scientific discoveries described in: Mailly et al. Nature Biotech 2015, Nakagawa et al. Cancer Cell 2016, Aizarani et al. Nature 2019, Hamdane et al. Gastroenterology 2019, Crouchet et al. Nat. Commun. 2021, Jühling et al. Gut. 2021.
What we offer
The institute is a world-class organization of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia and medical care. The successful candidate will benefit of:
- An international and vibrant state-of-the-art training environment
- Cutting-edge technologies including a single-cell RNASeq platform and the latest patient-derived cell-based and mouse models
- Close collaborations with pharma and world-class leaders in the field
- Tenure track program at Inserm and Unistra and excellent career opportunities in partnering industry
- For medical doctors: opportunities to receive PhD in translational research and concomitant hospital appointments
Profile
PhD or MD with a first publication record and ambition to drive an innovative program to success. Strong communicator with excellent command of English, both spoken and written. Drive and motivation to be an ERC fellow. You thrive in a fast-paced and exciting scientific environment with the opportunity for leading and driving a biomedical translational research program.
Senior Scientist in Drug Discovery and Development for Treatment of Hepatobiliary Cancer
The Inserm Institute for Viral and Liver Diseases, University of Strasbourg France, is looking for a talented and driven scientist to join Prof. Baumert’s highly ambitious FIBCAN program funded by a five-year ERC Advanced Grant of the European Research Council. The program is highly translational aiming to deliver transformative solutions for liver cancer. The successful candidate will contribute to drive and lead the preclinical development of breakthrough therapies for hepatobiliary cancer in collaboration with Pharma. A background in cancer research or immunology and experience in working in an international environment would be desirable. Our program is based on key scientific discoveries described in: Mailly et al. Nature Biotech 2015, Nakagawa et al. Cancer Cell 2016, Aizarani et al. Nature 2019, Hamdane et al. Gastroenterology 2019, Crouchet et al. Nat. Commun. 2021, Jühling et al. Gut. 2021.
What we offer
The institute is a world-class organization of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia and medical care. The successful candidate will benefit of:
- An international and vibrant state-of-the-art training environment
- Cutting-edge technologies including a single-cell RNASeq platform and the latest patient-derived cell-based and mouse models
- Close collaborations with pharma and world-class leaders in the field
- Tenure track program at Inserm and Unistra and excellent career opportunities in partnering industry
- For medical doctors: opportunities to receive PhD in translational research and concomitant hospital appointments
Profile
PhD or MD with a first publication record and ambition to drive an innovative program to success. Strong communicator with excellent command of English, both spoken and written. Drive and motivation to be an ERC fellow. You thrive in a fast-paced and exciting scientific environment with the opportunity for leading and driving a biomedical translational research program.
To apply
Please send your motivation letter (why you are interested in this position) and CV (including experience, track record and 2 academic references) to Prof. Thomas Baumert (Thomas.Baumert@unistra.fr) and Dr. Catherine Schuster (Catherine.Schuster@unistra.fr).